- Home
- PAXS vs NAGE Comparison
PAXS vs NAGE Comparison
Compare PAXS & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAXS
- NAGE
- Stock Information
- Founded
- PAXS 2021
- NAGE 1999
- Country
- PAXS United States
- NAGE United States
- Employees
- PAXS N/A
- NAGE N/A
- Industry
- PAXS Investment Managers
- NAGE Medicinal Chemicals and Botanical Products
- Sector
- PAXS Finance
- NAGE Health Care
- Exchange
- PAXS Nasdaq
- NAGE Nasdaq
- Market Cap
- PAXS 734.1M
- NAGE 766.4M
- IPO Year
- PAXS N/A
- NAGE N/A
- Fundamental
- Price
- PAXS N/A
- NAGE $7.47
- Analyst Decision
- PAXS
- NAGE Strong Buy
- Analyst Count
- PAXS 0
- NAGE 3
- Target Price
- PAXS N/A
- NAGE $17.00
- AVG Volume (30 Days)
- PAXS 195.0K
- NAGE 1.3M
- Earning Date
- PAXS 01-01-0001
- NAGE 10-30-2025
- Dividend Yield
- PAXS 11.72%
- NAGE N/A
- EPS Growth
- PAXS N/A
- NAGE N/A
- EPS
- PAXS N/A
- NAGE 0.22
- Revenue
- PAXS N/A
- NAGE $116,303,000.00
- Revenue This Year
- PAXS N/A
- NAGE $28.91
- Revenue Next Year
- PAXS N/A
- NAGE $20.89
- P/E Ratio
- PAXS N/A
- NAGE $34.71
- Revenue Growth
- PAXS N/A
- NAGE 35.90
- 52 Week Low
- PAXS $12.57
- NAGE $3.28
- 52 Week High
- PAXS $15.93
- NAGE $14.69
- Technical
- Relative Strength Index (RSI)
- PAXS 49.19
- NAGE 34.59
- Support Level
- PAXS $16.23
- NAGE $7.00
- Resistance Level
- PAXS $16.56
- NAGE $7.69
- Average True Range (ATR)
- PAXS 0.14
- NAGE 0.53
- MACD
- PAXS -0.03
- NAGE -0.09
- Stochastic Oscillator
- PAXS 32.76
- NAGE 18.89
About PAXS PIMCO Access Income Fund of Beneficial Interest
PIMCO Access Income Fund is a non-diversified, limited-term, closed-end management investment company. The fund seeks current income as an objective and capital appreciation as a secondary objective. It achieves the investment objectives by utilizing a dynamic asset allocation among multiple sectors in the public and private credit markets, including corporate debt.
About NAGE Niagen Bioscience Inc. Common Stock
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.